Welcome - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Search Results Your Search for 'Rheumatoid Arthritis - Pipeline Assessment and Market Forecasts to' returned 16 results - Page 1 of 1   Sort by    Date Published ASC Date Published DESC Report Price ASC Report Price DESC Rank ASC Rank DESC   Sorted by Rank Top-Bottom Rheumatoid Arthritis Drug Discoveries: what the future holds   Espicom Business Intelligence Ltd, March 2008, Pages: 250 Of Rheumatoid Arthritis Assessment Of Disease Activity And Response To Treatment CURRENT TREATMENT OPTIONS Diagnosis of Rheumatoid Arthritis Pharmacological Therapy Treatment Strategies PATIENT STATISTICS 2012 Global Infectious Disease Testing Market Outlook: Growth Opportunities and Strategies   Venture Planning Group, April 2012, Pages: 1900 and Diagnostics Sales Forecast by Market Segment France Rheumatoid Arthritis Test Volume and Diagnostics Sales Forecast by Market Segment France Rhinovirus Test Volume and Diagnostics Sales Forecast Breast Cancer Drug Discoveries: What the Future Holds   Espicom Business Intelligence Ltd, Aug 2011, Pages: 382 and scoring of 72 major breast cancer treatments Comprehensive market assessment of therapeutic approaches, company share, portfolios and prospects Breast Cancer Therapy Sales Forecast 2010 - 2017 'What The 2011 Infectious Disease Testing Market: US, Europe, Japan--Emerging Opportunities and Business Strategies for Suppliers   Venture Planning Group, Sep 2011, Pages: 1900 and Diagnostics Sales Forecast by Market Segment France RSV Test Volume and Diagnostics Sales Forecast by Market Segment France Rheumatoid Arthritis Test Volume and Diagnostics Sales Forecast by Market Segment Cytokine Therapeutics: Current and Future Markets in Inflammatory Disease   Decision Resources, Inc., Aug 2005, Pages: 17 Cytokine Therapeutics: Current and Future Markets in Inflammatory Disease Inflammatory diseases-both chronic diseases, such as rheumatoid arthritis (RA), and acute diseases, such as septic shock-pose 2012 France Infectious Disease Testing Market Outlook: Growth Opportunities and Strategies   Venture Planning Group, April 2012, Pages: 980 Forecast by Market Segment France Rheumatoid Arthritis Test Volume and Diagnostics Sales Forecast by Market Segment France Rhinovirus Test Volume and Diagnostics Sales Forecast by Market Segment France 2012 Japan Infectious Disease Testing Market Outlook: Growth Opportunities and Strategies   Venture Planning Group, April 2012, Pages: 976 and Diagnostics Sales Forecast by Market Segment Japan RSV Test Volume and Diagnostics Sales Forecast by Market Segment Japan Rheumatoid Arthritis Test Volume and Diagnostics Sales Forecast by Market Segment Japan 2012 Italy Infectious Disease Testing Market Outlook: Growth Opportunities and Strategies   Venture Planning Group, April 2012, Pages: 970 by Market Segment List of Tables (continued) Italy Rheumatoid Arthritis Test Volume and Diagnostics Sales Forecast by Market Segment Italy Rhinovirus Test Volume and Diagnostics Sales Forecast by Market Segment Italy 2012 Germany Infectious Disease Testing Market Outlook: Growth Opportunities and Strategies   Venture Planning Group, April 2012, Pages: 983 by Market Segment Germany Rheumatoid Arthritis Test Volume and Diagnostics Sales Forecast by Market Segment Germany Rhinovirus Test Volume and Diagnostics Sales Forecast by Market Segment Germany Rotavirus Test 2012 Spain Infectious Disease Testing Market Outlook: Growth Opportunities and Strategies   Venture Planning Group, April 2012, Pages: 960 Spain Rabies Test Volume and Diagnostics Sales Forecast by Market Segment Spain RSV Test Volume and Diagnostics Sales Forecast by Market Segment List of Tables (continued) Spain Rheumatoid Arthritis Test The 2011 German Infectious Disease Testing Market   Venture Planning Group, April 2010, Pages: 983 and Diagnostics Sales Forecast by Market Segment Germany RSV Test Volume and Diagnostics Sales Forecast by Market Segment Germany Rheumatoid Arthritis Test Volume and Diagnostics Sales Forecast by Market Segment 2012 UK Infectious Disease Testing Market Outlook: Growth Opportunities and Strategies   Venture Planning Group, April 2012, Pages: 978 Forecast by Market Segment U.K. Rabies Test Volume and Diagnostics Sales Forecast by Market Segment U.K. RSV Test Volume and Diagnostics Sales Forecast by Market Segment U.K. Rheumatoid Arthritis Test Volume Emerging Medical Technologies Spotlight, a Report of Investment & Partnering Opportunities 2010   Life Science Intelligence, Inc., Jan 2011 of action, for rheumatoid arthritis, anemia, organ transplants, and blood diseases - A drug-eluting stent coated with bioabsorbable polymers - Hand-held point-of-care and home-based testing devices Molecular Diagnostics - Technologies, Markets and Companies   Jain PharmaBiotech, May 2012, Pages: 1037 fever Achondroplasia Molecular diagnosis of eye diseases Molecular diagnosis of retinitis pigmentosa Genetic screening for glaucoma Role of molecular diagnostics in rheumatoid arthritis Molecular Belgium Pharmaceuticals and Healthcare Report Q2 2012   Business Monitor International, March 2012, Pages: 84 application to the Japanese Ministry of Health, Labour and Welfare for Cimzia in Q112. The drug is designed for the treatment of patients with rheumatoid arthritis. - In the same month, Belgian healthcare firm Future US Microbiology Testing Market Outlook   Venture Planning Group, Feb 2012, Pages: 1037 Supplier Italy RSV Testing Market Diagnostics Sales by Major Supplier Italy Rheumatoid Arthritis Testing Market Diagnostics Sales by Major Supplier Italy Rotavirus Testing Market Diagnostics Sales Results:  First -   Prev -   1 -   Next -   Last

		For enquiries please call us on:   +353-1-415-1241 (GMT Office Hours)   1-800-526-8630 (US/Canada Toll Free)   1-917-300-0470 (EST Office Hours)

All rights reserved. © Copyright 2012 Research and Markets2    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network